Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Interleukin 1 receptor antagonist (disposition) |
Is a |
True |
Interleukin receptor antagonist (disposition) |
Inferred relationship |
Some |
|
Guselkumab (substance) |
This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. |
False |
Interleukin receptor antagonist (disposition) |
Inferred relationship |
Some |
|
Interleukin 5 receptor antagonist |
Is a |
True |
Interleukin receptor antagonist (disposition) |
Inferred relationship |
Some |
|
Interleukin 4 receptor alpha antagonist |
Is a |
True |
Interleukin receptor antagonist (disposition) |
Inferred relationship |
Some |
|
Interleukin receptor antagonist |
This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. |
True |
Interleukin receptor antagonist (disposition) |
Inferred relationship |
Some |
|
Substance with interleukin 5 receptor antagonist mechanism of action (substance) |
This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. |
False |
Interleukin receptor antagonist (disposition) |
Inferred relationship |
Some |
|
Mepolizumab (substance) |
This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. |
False |
Interleukin receptor antagonist (disposition) |
Inferred relationship |
Some |
|
Brodalumab (substance) |
This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. |
True |
Interleukin receptor antagonist (disposition) |
Inferred relationship |
Some |
|
Interleukin-4 receptor alpha antagonist |
This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. |
False |
Interleukin receptor antagonist (disposition) |
Inferred relationship |
Some |
|
Dupilumab |
This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. |
False |
Interleukin receptor antagonist (disposition) |
Inferred relationship |
Some |
|
Sarilumab (substance) |
This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. |
False |
Interleukin receptor antagonist (disposition) |
Inferred relationship |
Some |
|
Interleukin 23 receptor antagonist (disposition) |
Is a |
True |
Interleukin receptor antagonist (disposition) |
Inferred relationship |
Some |
|
Benralizumab |
This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. |
True |
Interleukin receptor antagonist (disposition) |
Inferred relationship |
Some |
|
Interleukin 3 receptor alpha antagonist (disposition) |
Is a |
True |
Interleukin receptor antagonist (disposition) |
Inferred relationship |
Some |
|
Interleukin 6 receptor antagonist (disposition) |
Is a |
True |
Interleukin receptor antagonist (disposition) |
Inferred relationship |
Some |
|
Ixekizumab (substance) |
This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. |
True |
Interleukin receptor antagonist (disposition) |
Inferred relationship |
Some |
|
Recombinant interleukin 1 receptor antagonist (disposition) |
Is a |
True |
Interleukin receptor antagonist (disposition) |
Inferred relationship |
Some |
|
Bimekizumab (substance) |
This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. |
True |
Interleukin receptor antagonist (disposition) |
Inferred relationship |
Some |
|
Tralokinumab (substance) |
This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. |
False |
Interleukin receptor antagonist (disposition) |
Inferred relationship |
Some |
|
Interleukin 13 receptor antagonist (disposition) |
Is a |
True |
Interleukin receptor antagonist (disposition) |
Inferred relationship |
Some |
|
Interleukin 36 receptor antagonist (disposition) |
Is a |
True |
Interleukin receptor antagonist (disposition) |
Inferred relationship |
Some |
|